Status: Not yet recruiting
Assessment of Combined Praziquantel and Albendazole vs Albendazole Alone to Treat Active Parenchymal Neurocysticercosis
The goal of this clinical trial is to compare the combination albendazole and praziquantel versus albendazole alone in patients affected by neurocysticercosis.
Participants needed: 300
Trial details
Phase: Phase 4Age: 18+Biological sex: AllType: InterventionalSponsor: R-Evolution Worldwide S.r.l. Impresa SocialeUpdated: Apr 23, 2024
Eligibility criteria
Living in the study area for a continuous period of 3 years [+8]
Women pregnant or breastfeeding [+6]